Zymeworks, Inc. (ZYME)
26.79
+0.55
(+2.10%)
USD |
NASDAQ |
Sep 14, 14:50
Zymeworks Price to Book Value : 23.99 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 23.50 |
| September 10, 2026 | 23.67 |
| September 09, 2026 | 24.31 |
| September 08, 2026 | 25.17 |
| September 04, 2026 | 26.14 |
| September 03, 2026 | 26.77 |
| September 02, 2026 | 27.80 |
| September 01, 2026 | 26.57 |
| August 31, 2026 | 26.33 |
| August 28, 2026 | 25.31 |
| August 27, 2026 | 25.98 |
| August 26, 2026 | 26.24 |
| August 25, 2026 | 24.60 |
| August 24, 2026 | 25.76 |
| August 21, 2026 | 25.67 |
| August 20, 2026 | 23.79 |
| August 19, 2026 | 24.36 |
| August 18, 2026 | 23.34 |
| August 17, 2026 | 22.66 |
| August 14, 2026 | 22.49 |
| August 13, 2026 | 23.07 |
| August 12, 2026 | 22.32 |
| August 11, 2026 | 21.78 |
| August 10, 2026 | 21.63 |
| August 07, 2026 | 21.08 |
| Date | Value |
|---|---|
| August 06, 2026 | 20.71 |
| August 05, 2026 | 21.04 |
| August 04, 2026 | 20.41 |
| August 03, 2026 | 19.53 |
| July 31, 2026 | 19.65 |
| July 30, 2026 | 20.33 |
| July 29, 2026 | 19.71 |
| July 28, 2026 | 20.24 |
| July 27, 2026 | 20.59 |
| July 24, 2026 | 20.47 |
| July 23, 2026 | 20.70 |
| July 22, 2026 | 20.92 |
| July 21, 2026 | 21.53 |
| July 20, 2026 | 21.27 |
| July 17, 2026 | 21.66 |
| July 16, 2026 | 21.66 |
| July 15, 2026 | 22.08 |
| July 14, 2026 | 22.08 |
| July 13, 2026 | 22.33 |
| July 10, 2026 | 23.17 |
| July 09, 2026 | 24.24 |
| July 08, 2026 | 23.86 |
| July 07, 2026 | 23.93 |
| July 06, 2026 | 22.68 |
| July 02, 2026 | 23.56 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Theravance Biopharma, Inc. | 3.049 |
| AbbVie, Inc. | -- |
| BridgeBio Pharma, Inc. | -- |
| Aprea Therapeutics, Inc. | 0.2523 |
| ACADIA Pharmaceuticals, Inc. | 3.623 |
Price to Book Value Related Metrics
| PS Ratio | 53.90 |
| PEG Ratio | -0.1261 |
| Price | 26.79 |
| Earnings Yield | -7.52% |
| Market Cap | 1.928B |
| PEGY Ratio | -0.1261 |